Knowledge Hub

Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Press Release   •   Nov 24, 2016 05:35 EST

Summary

The report, Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016" provides an overview of Ovarian Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ovarian Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Scope

- Extensive coverage of the Ovarian Cancer Diagnostic Tests under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Ovarian Cancer Diagnostic Tests and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Download Sample Copy of Report at http://www.marketresearchreports.biz/sample/sample/825726

Reasons to buy

The report enables you to -

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Ovarian Cancer Diagnostic Tests under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the products current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents 2

1.1 List of Tables 7

1.2 List of Figures 14

2 Introduction 15

2.1 Ovarian Cancer Diagnostic Tests Overview 15

3 Products under Development 16

3.1 Ovarian Cancer Diagnostic Tests - Pipeline Products by Stage of Development 16

3.2 Ovarian Cancer Diagnostic Tests - Pipeline Products by Territory 17

3.3 Ovarian Cancer Diagnostic Tests - Pipeline Products by Regulatory Path 18

3.4 Ovarian Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date 19

3.5 Ovarian Cancer Diagnostic Tests - Ongoing Clinical Trials 20

4 Ovarian Cancer Diagnostic Tests - Pipeline Products under Development by Companies 21

4.1 Ovarian Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development 21

4.2 Ovarian Cancer Diagnostic Tests - Pipeline Products by Stage of Development 25

5 Ovarian Cancer Diagnostic Tests Companies and Product Overview 29

5.1 A&G Pharmaceutical, Inc. Company Overview 29

5.2 Abnova Corporation Company Overview 31

5.3 Almac Diagnostics Limited Company Overview 33

5.4 ANGLE plc Company Overview 34

5.5 AroCell AB Company Overview 37

5.6 ArtemixRx Company Overview 38

5.7 Augusta University Company Overview 39

5.8 Aurelium BioPharma Inc. Company Overview 40

5.9 Avant Diagnostics, Inc. Company Overview 43

5.10 Axela Inc. Company Overview 44